TCT-359 Late Outcome of the First-in-Human Study of the Colibri Dry, Pre-mounted, Pre-packaged TAVR Valve

TCT-359 Late Outcome of the First-in-Human Study of the Colibri Dry, Pre-mounted, Pre-packaged TAVR Valve

Background The Colibri heart valve (CHV) is a pre-mounted, pre-packaged, low-profile, ready-for-use dry TAVR valve with conical cusp design mounted upon a balloon-expandable delivery system encapsulated within within a 14 Fr sheath. Conclusion In the first human cases of the Colibri pre-mounted dry...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B148-B148
Hauptverfasser: Fish, Richard, Paniagua, David
Format: Artikel
Sprache:eng
Schlagworte:
Balloon treatment
Cardiology
Colibri
FDA approval
Feasibility studies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The Colibri heart valve (CHV) is a pre-mounted, pre-packaged, low-profile, ready-for-use dry TAVR valve with conical cusp design mounted upon a balloon-expandable delivery system encapsulated within within a 14 Fr sheath. Conclusion In the first human cases of the Colibri pre-mounted dry valve technology, clinical outcome early and in late survivors showed sustained clinical benefits.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.1148